2月12日 - ** Vertex Pharmaceuticals VRTX.O股价在盘后交易中下跌1.1%，至460.07美元
** 公司报告第四季度调整后每股利润为5.03美元，低于LSEG数据显示的预期的每股5.07美元。
** 预测2026年营收在129.5亿美元至131亿美元之间，中间值与分析师预计的130.2亿美元一致
** 第四季度营收为31.9亿美元，高于分析师预计的31.8亿美元
** 2025 年 VRTX 增长 12.6%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.